News
The pharmaceutical giant sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused ...
A decision to possibly sell the business, which was poised to become the centerpiece of a restructuring plan, represents a shift in strategy by new company leaders.
The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck small research deals.
TCG Labs Soleil, which launched in 2024 in collaboration with The Column Group, is focused on building single-drug biotechs it can position for partnerships.
The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results